These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6189236)

  • 1. Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate.
    Dunn F; Soria J; Soria C; Thomaidis A; Tobelem G; Caen JP
    Thromb Res; 1983 Jan; 29(2):141-8. PubMed ID: 6189236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between commercial heparin, low molecular weight heparin and pentosan polysulfate on hemostasis and platelets in vivo.
    Esquivel CO; Bergqvist D; Björck CG; Nilsson B
    Thromb Res; 1982 Nov; 28(3):389-99. PubMed ID: 6184845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of platelets with standard heparin and low molecular weight fractions.
    Dunn FW; Soria C; Thomaidis A; Soria J; Dupuy E; Bellucci S; Tobelem G
    Nouv Rev Fr Hematol (1978); 1984; 26(4):249-53. PubMed ID: 6089103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant activities of a pentosane polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin.
    Soria C; Soria J; Ryckewaert JJ; Holmer E; Caen JP
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):455-63. PubMed ID: 6160640
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentosan polysulfate-induced thrombocytopenia and thrombosis.
    Tardy-Poncet B; Tardy B; Grelac F; Reynaud J; Mismetti P; Bertrand JC; Guyotat D
    Am J Hematol; 1994 Mar; 45(3):252-7. PubMed ID: 7507640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence on the clotting mechanism of sodium pentosan polysulfate (SP54) in comparison to commercial beef lung sodium heparin.
    Vinazzer H; Haas S; Stemberger A
    Thromb Res; 1980 Oct; 20(1):57-68. PubMed ID: 6163222
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia and pentosan polysulfate: treatment with a low molecular weight heparin despite in vitro platelet aggregation.
    Vitoux JF; Roncato M; Hourdebaigt P; Aiach M; Fiessinger JN
    Thromb Haemost; 1986 Apr; 55(2):294-5. PubMed ID: 2424119
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.
    Messmore HL; Griffin B; Koza M; Seghatchian J; Fareed J; Coyne E
    Semin Thromb Hemost; 1991; 17 Suppl 1():57-9. PubMed ID: 1712512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation and anticoagulant properties of a new sulfated xylan: comparison with heparin and a sodium pentosan polysulfate (SP-54).
    Doctor VM; Sauls V
    Thromb Res; 1983 Jun; 30(6):573-8. PubMed ID: 6193601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin modulates integrin function in human platelets.
    Sobel M; Fish WR; Toma N; Luo S; Bird K; Mori K; Kusumoto S; Blystone SD; Suda Y
    J Vasc Surg; 2001 Mar; 33(3):587-94. PubMed ID: 11241131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic inhibition by antithrombin III and heparin-like compounds of thrombin-induced platelet aggregation [proceedings].
    Kindness G; Williamson FB; Long WF
    Biochem Soc Trans; 1980 Feb; 8(1):85-6. PubMed ID: 6154614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myocardial infarct complicating thrombopenia induced by pentosan polysulfate].
    Dalger J; Dussarat GV; Dumoulin M
    Ann Cardiol Angeiol (Paris); 1988 Apr; 37(4):191-3. PubMed ID: 2453137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology of a heparinoid derived from pentosan].
    Lansen J; Diner H
    Agressologie; 1983 Dec; 24(12):591-5. PubMed ID: 6199994
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disseminated coronary thrombosis and thrombopenia induced by pentosan polysulfate].
    Meyer P; Couzi G; Bavle J; Blanc P; Gibelin P; Camous JP; Morand P
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):913-9. PubMed ID: 2461180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allergic thrombopenia induced by heparin or pentosan polysulfate].
    Bayle J; Chichmanian RM; Caramella A; Mignot G; Spreux A; Samat C; Macci P
    Therapie; 1986; 41(5):339-43. PubMed ID: 2433783
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationale behind the development of low molecular weight heparin derivatives.
    Hirsh J; Ofosu F; Buchanan M
    Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.
    Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B
    Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet aggregation studies for the diagnosis of heparin-induced thrombocytopenia.
    Isenhart CE; Brandt JT
    Am J Clin Pathol; 1993 Mar; 99(3):324-30. PubMed ID: 8447295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfated polysaccharides modulate effects of acidic and basic fibroblast growth factors on repair of injured confluent human vascular endothelium.
    Klein-Soyer C; Beretz A; Cazenave JP; Wittendorp-Rechenmann E; Vonesch JL; Rechenmann RV; Driot F; Maffrand JP
    Arteriosclerosis; 1989; 9(2):147-53. PubMed ID: 2466455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.